HANSA BIOPHARMA AB Quotes Hansa Biopharma AB Börse Stuttgart
Equities
24H
SE0002148817
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.242 EUR | +1.34% |
|
+13.07% | +78.58% |
| 05-31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
| 05-31 | Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial | CI |
Quotes 5-day view
Delayed Quote Börse Stuttgart| 2024-06-21 | 2024-06-24 | 2024-06-25 | 2024-06-26 | 2024-06-27 | |
|---|---|---|---|---|---|
| Last | 3.684 € | 3.676 € | 4.058 € | 4.186 € | 4.242 € |
| Change | +1.71% | -0.22% | +10.39% | +3.15% | +1.34% |
Performance
| 1 week | +13.07% | ||
| Current month | +0.34% | ||
| 1 month | +16.80% | ||
| 3 months | +67.57% | ||
| 6 months | +99.71% | ||
| Current year | +78.58% | ||
| 1 year | +8.39% | ||
| 3 years | -69.21% | ||
| 5 years | -72.94% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
3 322 040 546
Capitalization (USD)
313 471 068
Net sales (SEK)
134 094 000
Net sales (USD)
12 653 244
Free-Float
88.64 %
Free-Float capitalization (EUR)
2 379 805 884
Free-Float capitalization (USD)
224 560 863
Highs and lows
1 week
3.62
4.32
1 month
3.374.77
3 years
1.7214.95
5 years
1.7227.58
Indicators
Moving average 5 days
3.85
Moving average 20 days
4.13
Moving average 50 days
3.33
Moving average 100 days
3.05
Price spread / (MMA5)
-9.35%
Price spread / (MMA20)
-2.54%
Price spread / (MMA50)
-21.61%
Price spread / (MMA100)
-28.09%
RSI 9 days
55.01
RSI 14 days
56.31
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +80.97% | ||
| 2023 | -47.09% | ||
| 2022 | -46.20% | ||
| 2021 | -64.69% | ||
| 2020 | +202.46% | ||
| 2019 | -70.28% | ||
| 2018 | +5.51% | ||
| 2017 | +112.01% |
- Stock Market
- Equities
- HNSA Stock
- 24H Stock
- Quotes Hansa Biopharma AB
